如何(不)在研究中承担责任:对批评我的人的回复。

IF 2.8 1区哲学 Q1 MEDICAL ETHICS

Accountability in Research-Policies and Quality Assurance Pub Date : 2023-07-01 DOI:10.1080/08989621.2023.2193694

Hans Radder

{"title":"如何(不)在研究中承担责任:对批评我的人的回复。","authors":"Hans Radder","doi":"10.1080/08989621.2023.2193694","DOIUrl":null,"url":null,"abstract":"Many drugs of limited value are approved by regulatory agencies. One of the factors contributing thereto is financial conflict of interest (FCI) with the pharmaceutical industry (Pharma). This occurs at different levels, including researchers, opinion leaders and editors of medical journals. FCI contributes to patient expo-sure to treatments that offer limited or no benefit and to unjust spending of valuable resources while providing large revenues for Pharma. 1","PeriodicalId":50927,"journal":{"name":"Accountability in Research-Policies and Quality Assurance","volume":"30 5","pages":"284-291"},"PeriodicalIF":2.8000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How (not) to be held accountable in research: A reply to my critics.\",\"authors\":\"Hans Radder\",\"doi\":\"10.1080/08989621.2023.2193694\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Many drugs of limited value are approved by regulatory agencies. One of the factors contributing thereto is financial conflict of interest (FCI) with the pharmaceutical industry (Pharma). This occurs at different levels, including researchers, opinion leaders and editors of medical journals. FCI contributes to patient expo-sure to treatments that offer limited or no benefit and to unjust spending of valuable resources while providing large revenues for Pharma. 1\",\"PeriodicalId\":50927,\"journal\":{\"name\":\"Accountability in Research-Policies and Quality Assurance\",\"volume\":\"30 5\",\"pages\":\"284-291\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accountability in Research-Policies and Quality Assurance\",\"FirstCategoryId\":\"98\",\"ListUrlMain\":\"https://doi.org/10.1080/08989621.2023.2193694\",\"RegionNum\":1,\"RegionCategory\":\"哲学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICAL ETHICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accountability in Research-Policies and Quality Assurance","FirstCategoryId":"98","ListUrlMain":"https://doi.org/10.1080/08989621.2023.2193694","RegionNum":1,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL ETHICS","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

How (not) to be held accountable in research: A reply to my critics.

Many drugs of limited value are approved by regulatory agencies. One of the factors contributing thereto is financial conflict of interest (FCI) with the pharmaceutical industry (Pharma). This occurs at different levels, including researchers, opinion leaders and editors of medical journals. FCI contributes to patient expo-sure to treatments that offer limited or no benefit and to unjust spending of valuable resources while providing large revenues for Pharma. 1

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Accountability in Research-Policies and Quality Assurance MEDICAL ETHICS-

CiteScore

4.90

自引率

14.70%

发文量

审稿时长

>12 weeks

期刊介绍： Accountability in Research: Policies and Quality Assurance is devoted to the examination and critical analysis of systems for maximizing integrity in the conduct of research. It provides an interdisciplinary, international forum for the development of ethics, procedures, standards policies, and concepts to encourage the ethical conduct of research and to enhance the validity of research results. The journal welcomes views on advancing the integrity of research in the fields of general and multidisciplinary sciences, medicine, law, economics, statistics, management studies, public policy, politics, sociology, history, psychology, philosophy, ethics, and information science. All submitted manuscripts are subject to initial appraisal by the Editor, and if found suitable for further consideration, to peer review by independent, anonymous expert referees.